Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-242 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-542 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-242 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-54 |
filingDate |
2020-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2022-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2022-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-111568922-B |
titleOfInvention |
Treatment of adverse effects from atypical antipsychotics |
abstract |
Use of ligand-bound gold clusters and compositions containing the ligand-bound gold clusters in the treatment of adverse reactions caused by atypical antipsychotics and in the preparation of medicaments for the treatment of adverse reactions caused by atypical antipsychotics. Methods for the treatment of adverse reactions from atypical antipsychotics. |
priorityDate |
2020-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |